Back to Screener

Healthcare

BioArctic AB (publ)(BRCTF)

Live Price

Offline

$35.00

+0.00% today

Window Change

+6.00%

Window

May 4, 2026 โ†’ Jun 23, 2026

Market Cap
$28.85B
Revenue Growth
+674.9%
EPS Growth
+676.0%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 36 bars ยท May 4, 2026 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioArctic AB (publ) (BRCTF) is a Healthcare stock with a market cap of $28.85B. The stock last traded around $35.00 and up 6.0% across the available one-year price window (May 4, 2026 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +674.9%, EPS growth of +676.0%, a dividend yield of 0.0%. What stands out right now is revenue +674.9%, EPS +676.0%, free cash flow +100.0% with operating margin 63.0% and ROIC 49.6%. Valuation already assumes a fairly strong business story at P/E 28.1 and price/sales 14.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines BRCTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+674.9% vs +7.6% peer median

Operating Margin

Above sector median

+63.0% vs +19.4% peer median

P/E

Below sector median

28.1 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 20, 2026, but the surprise data is still limited.

The operating story is still moving forward

Revenue is running at +674.9% and EPS at +676.0%, with operating margin around 63.0%.

Benchmark Edge

BRCTF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BRCTF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BRCTF Max Drawdown

-9.68%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BRCTF and SPY.

Calendar-year return history is still loading or unavailable.
BI

Company Overview

BioArctic AB (publ)

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
28.1
EV/EBITDA
21.7
Price/Sales
14.4
Price/Book
14.6

Growth

Revenue
+674.9%
EPS
+676.0%
Free Cash Flow
+100.0%

Profitability

Gross Margin
97.0%
Operating Margin
63.0%
Net Margin
51.1%
ROE
51.7%
ROIC
49.6%

Balance Sheet

Debt/Equity
0.04
Current Ratio
4.78

Earnings Reports

๐Ÿ“… Last reportedMay 20, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 20, 26
โ€”
Est -0.03
โ€”
โ€”
Est 21023.1B
โ€”
โ€”
Feb 18, 26
โœ“
-0.01
Est -0.06
+81.5%
19908.8B
Est 18060.2B
+10.2%
โ€”
Nov 13, 25
โœ“
-0.10
Est -0.12
+13.8%
1505.9B
Est 18173.1B
-91.7%
โ€”
Jun 30, 25
โœ—
0.11
Est 0.16
-29.6%
40972.5B
Est 38541.6B
+6.3%
โ€”
Mar 31, 25
โœ“
1.15
Est 1.03
+11.7%
128820.9B
Est 127036.8B
+1.4%
โ€”
Dec 31, 24
โœ“
-0.03
Est -0.06
+43.9%
9111.2B
Est 8857.8B
+2.9%
โ€”
Sep 30, 24
โœ“
-0.02
Est -0.06
+64.8%
7386.1B
Est 7218.3B
+2.3%
โ€”
Jun 30, 24
โœ—
-0.07
Est -0.07
-2.7%
4715.8B
Est 4445.9B
+6.1%
โ€”
Mar 31, 24
โœ“
-0.06
Est -0.08
+22.9%
2732.7B
Est 1700.3B
+60.7%
โ€”
Dec 31, 23
โœ—
-0.10
Est -0.08
-25.3%
1090.4B
Est 1569.3B
-30.5%
โ€”
Sep 30, 23
โœ“
0.13
Est 0.02
+601.8%
18957.8B
Est 10852.8B
+74.7%
โ€”
Jun 30, 23
โœ—
-0.11
Est -0.09
-18.2%
249.4B
Est 276.9B
-9.9%
โ€”
Mar 31, 23
0.32
Est โ€”
โ€”
37800.8B
Est โ€”
โ€”
โ€”
Feb 3, 23
-0.06
Est โ€”
โ€”
204.1B
Est โ€”
โ€”
โ€”
Sep 30, 22
0.14
Est โ€”
โ€”
19476.2B
Est โ€”
โ€”
โ€”
Jun 30, 22
-0.05
Est โ€”
โ€”
412.1B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.